Fact CheckerSign in

NCT06931483Enrolling by invitation

The Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) Targeting the Right Globus Pallidus Internus (GPi) for Motor Symptoms in Patients With PD

Source: ClinicalTrials.gov · Last updated 17 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To demonstrate that intervention targeting the right globus pallidus internus (GPi) using transcranial temporal interference stimulation can improve motor symptoms in patients with Parkinson's disease.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
40 (estimated)
First submitted
9 Apr 2025
Start date
1 Sept 2024
Primary completion date
30 Sept 2025
Lead sponsor
Yanghua Tian
NCT number
NCT06931483

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 1 Sept 2024 to the primary completion date, 30 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous history of TMS or traditional TES treatment;
  • Presence of non-MRI compatible metal implants in the body, such as deep brain stimulation devices, pacemakers or stents.

Other illness

  • History of other neuropsychiatric disorders;
  • History of alcohol or drug abuse;

Who the study is looking for

  • Meeting the diagnostic criteria for Parkinson's disease in China (2016 version), diagnosed as PD by two neurologists;
  • Hoehn-Yahr stage 1.5-4;
  • Age \> 50 years old;
  • No signs of moderate to severe depression: Beck Depression Inventory-II (BDI-II) score \< 20;
  • No signs of dementia: Mini-Mental State Examination (MMSE) score \> 21;
  • No change in medication regimen in the four weeks prior to enrollment;
  • Right-handed.

Age in the registry: 50 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Anhui Medical University
Coordinator of this site? Confirm its status
HefeiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.